HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Adams Brings Mucinex To Pediatric Market; Humibid Launch Slated For March

This article was originally published in The Tan Sheet

Executive Summary

Adams Respiratory Therapeutics will launch a line of cough/cold products for children under the Mucinex brand name by the end of 2006

You may also be interested in...

Adams Delays New Humibid Launches, Mucinex Drives Record Overall Sales

In the midst of strong growth from flagship brand Mucinex, Adams is delaying the launch of new Humibid products to train pharmacists in behind-the-counter sale of the OTC drug

OTC Makers Target Children With Mucinex Mini Melts, Triaminic For Infants

Several OTC manufacturers are focusing on the adolescent and children's markets with product launches planned for the 2006-2007 cough/cold season

Adams Expands OTC Cough Market Presence With Delsym Acquisition

Adams Respiratory Therapeutics intends to aggressively promote Delsym cough suppressant to consumers following its May 24 acquisition of the brand

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts